secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eledon Pharmaceuticals, Inc. (ELDN)
CIK:        0001404281
Form:       8-K
Filed at:   2023-10-02T23:59:59+00:00
Accession:  0000950170-23-050925
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Eledon Pharmaceuticals appoints Dr. Allan Douglas Kirk to board of directors
----------------------------------------------------------------------------

- Board expands from 8 to 9 directors; Dr. Kirk effective Oct 2, 2023.
- Determined independent under Nasdaq rules; will serve on Science and Technology Committee.
- Annual cash retainers: $42,000 for board service, $7,875 for committee service.
- Granted option for 150,437 shares at market price on Oct 2, 2023; vests over 2 years.
- Enters standard indemnification agreement for directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404281/000095017023050925/0000950170-23-050925-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404281/000095017023050925/eldn-20230929.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-050925

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer